These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26431622)

  • 21. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
    Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
    Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disturbance of the glutamatergic system by glutaric acid in striatum and cerebral cortex of glutaryl-CoA dehydrogenase-deficient knockout mice: possible implications for the neuropathology of glutaric acidemia type I.
    Busanello EN; Fernandes CG; Martell RV; Lobato VG; Goodman S; Woontner M; de Souza DO; Wajner M
    J Neurol Sci; 2014 Nov; 346(1-2):260-7. PubMed ID: 25241940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
    Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
    Pharmacology; 2006; 76(4):157-62. PubMed ID: 16446560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role of astrocytes in mediating postnatal neurodegeneration in Glutaric acidemia-type 1.
    Olivera-Bravo S; Barbeito L
    FEBS Lett; 2015 Nov; 589(22):3492-7. PubMed ID: 26409499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.
    Aguirre-Rueda D; Guerra-Ojeda S; Aldasoro M; Iradi A; Obrador E; Mauricio MD; Vila JM; Marchio P; Valles SL
    PLoS One; 2015; 10(4):e0122843. PubMed ID: 25874692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites.
    Harting I; Boy N; Heringer J; Seitz A; Bendszus M; Pouwels PJ; Kölker S
    J Inherit Metab Dis; 2015 Sep; 38(5):829-38. PubMed ID: 25860816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organic acidurias in adults: late complications and management.
    Tuncel AT; Boy N; Morath MA; Hörster F; Mütze U; Kölker S
    J Inherit Metab Dis; 2018 Sep; 41(5):765-776. PubMed ID: 29335813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
    Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ
    Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutaric acidemia type 1.
    Hedlund GL; Longo N; Pasquali M
    Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):86-94. PubMed ID: 16602100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
    Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The unsolved puzzle of neuropathogenesis in glutaric aciduria type I.
    Jafari P; Braissant O; Bonafé L; Ballhausen D
    Mol Genet Metab; 2011 Dec; 104(4):425-37. PubMed ID: 21944461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal neuronal death mediated by astrocytes from the Gcdh-/- mouse model of glutaric acidemia type I.
    Olivera-Bravo S; Ribeiro CA; Isasi E; Trías E; Leipnitz G; Díaz-Amarilla P; Woontner M; Beck C; Goodman SI; Souza D; Wajner M; Barbeito L
    Hum Mol Genet; 2015 Aug; 24(16):4504-15. PubMed ID: 25968119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid-induced changes in respiration of brain mitochondria.
    Fišar Z; Singh N; Hroudová J
    Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I.
    Jafari P; Braissant O; Zavadakova P; Henry H; Bonafé L; Ballhausen D
    PLoS One; 2013; 8(1):e53735. PubMed ID: 23326493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of age at onset and newborn screening on outcome in organic acidurias.
    Heringer J; Valayannopoulos V; Lund AM; Wijburg FA; Freisinger P; Barić I; Baumgartner MR; Burgard P; Burlina AB; Chapman KA; I Saladelafont EC; Karall D; Mühlhausen C; Riches V; Schiff M; Sykut-Cegielska J; Walter JH; Zeman J; Chabrol B; Kölker S;
    J Inherit Metab Dis; 2016 May; 39(3):341-353. PubMed ID: 26689403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocytic proliferation and mitochondrial dysfunction induced by accumulated glutaric acidemia I (GAI) metabolites: possible implications for GAI pathogenesis.
    Olivera S; Fernandez A; Latini A; Rosillo JC; Casanova G; Wajner M; Cassina P; Barbeito L
    Neurobiol Dis; 2008 Dec; 32(3):528-34. PubMed ID: 18930146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
    Sauer SW; Opp S; Hoffmann GF; Koeller DM; Okun JG; Kölker S
    Brain; 2011 Jan; 134(Pt 1):157-70. PubMed ID: 20923787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane translocation of glutaric acid and its derivatives.
    Mühlhausen C; Burckhardt BC; Hagos Y; Burckhardt G; Keyser B; Lukacs Z; Ullrich K; Braulke T
    J Inherit Metab Dis; 2008 Apr; 31(2):188-93. PubMed ID: 18404412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.